Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Remote monitoring for patients after heart valve replacement

Official title: Remote Acute Monitoring-based Same-day Discharge Strategy of Post Transcatheter Aortic Valve Implantation Patients Versus Standard Care at 30-Day Follow-up

Run by Imperial College London · NCT06602609 · Data updated 2026-11-12

This study tests if using remote monitoring can help patients who have had heart valve replacement recover better and go home sooner by catching any problems early.

More Digital Health trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment216 (estimated)
SponsorImperial College London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedJuly 1, 2027
Study endsJuly 1, 2028
Registry record updatedMarch 3, 2026
Trial IDNCT06602609 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have undergone TAVI without serious complications and are eligible for same-day discharge.

Probably not a fit

Patients with hemodynamic instability or significant complications post-TAVI that require inpatient care will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to implement a remote monitoring algorithm to collect vital clinical data for patients who have undergone Transcatheter Aortic Valve Implantation (TAVI). By utilizing technology, the study seeks to reduce hospital length of stay and readmissions by addressing potential heart conduction issues that may arise post-procedure. Eligible patients will be monitored remotely to predict and manage any complications, allowing for same-day discharge when appropriate. The trial will assess whether this approach can effectively enhance patient care and outcomes following TAVI.

Why it matters

Potential benefit: If successful, this approach could lead to shorter hospital stays and improved management of post-TAVI complications for patients.

How similar studies have gone: Previous studies have shown promise in using remote monitoring for post-operative care, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient age must be 18 years or above.
* Post-TAVI patients without serious complications hindering same-day discharge, including vascular, neurological, and cardiac postprocedural complications necessitating inpatient care:
* Vascular: Controlled with adequate vascular hemostasis.
* Neurological: Conscious and oriented, not under the effect of residual sedation.
* Cardiac: No significant pericardial effusion.
* Elective non-emergent patient admission and nonelective cases fitting discharge criteria.
* Comfortable ambulation post-procedure.
* The patient or their caregiver must have access to a smart device.
* Ability to provide informed consent (the patient must be alert and oriented for consent).
* Adequate social support.

Exclusion Criteria:

* Hemodynamically unstable post-TAVI condition, periprocedural cardiac arrest, cerebral vascular accident, acute kidney injury (AKI) and major/life-threatening bleeding requiring blood transfusion.
* Patients with a permanent (pre-existing or new) implanted pacing device.
* Procedural failure in device delivery.
* Major vascular access complications require patients to stay.
* Inability to engage with the technology.
* Significant communication barrier.

Where it's running

  • Hammersmith Hospital
    London, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Ramzi Khamis, MBChB DIC PhD FESC FRCP — Imperial College London, Imperial College Healthcare NHS Trust
  • Study coordinator: Badr Al Harbi, BScEMS, MSc
  • Email: b.al-harbi23@imperial.ac.uk
  • Phone: +44(0)7771429219

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.